BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 12963986)

  • 1. Potential antitumor effects of statins (Review).
    Jakobisiak M; Golab J
    Int J Oncol; 2003 Oct; 23(4):1055-69. PubMed ID: 12963986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.
    Graaf MR; Richel DJ; van Noorden CJ; Guchelaar HJ
    Cancer Treat Rev; 2004 Nov; 30(7):609-41. PubMed ID: 15531395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotropic effects of statins and related pharmacological experimental approaches.
    Alegret M; Silvestre JS
    Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMG-CoA reductase inhibitors (statins) as anticancer drugs (review).
    Fritz G
    Int J Oncol; 2005 Nov; 27(5):1401-9. PubMed ID: 16211237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins in tumor suppression.
    Sassano A; Platanias LC
    Cancer Lett; 2008 Feb; 260(1-2):11-9. PubMed ID: 18180097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
    Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy insight: Potential of statins for cancer chemoprevention and therapy.
    Katz MS
    Nat Clin Pract Oncol; 2005 Feb; 2(2):82-9. PubMed ID: 16264880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
    Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
    Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins can modulate effectiveness of antitumor therapeutic modalities.
    Jakobisiak M; Golab J
    Med Res Rev; 2010 Jan; 30(1):102-35. PubMed ID: 19526461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The statins as anticancer agents.
    Chan KK; Oza AM; Siu LL
    Clin Cancer Res; 2003 Jan; 9(1):10-9. PubMed ID: 12538446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory effects of HMG-CoA reductase inhibitors.
    Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
    Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin use and cancer risk: an epidemiologic review.
    Friis S; Olsen JH
    Cancer Invest; 2006; 24(4):413-24. PubMed ID: 16777695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic effects of statins and related pharmacological experimental approaches.
    Alegret M; Silvestre JS
    Timely Top Med Cardiovasc Dis; 2007 Apr; 11():E10. PubMed ID: 17473899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory effects of statins and autoimmune rheumatic diseases: novel intracellular mechanism involved.
    Tristano AG; Fuller K
    Int Immunopharmacol; 2006 Dec; 6(12):1833-46. PubMed ID: 17052674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho GTPases: promising cellular targets for novel anticancer drugs.
    Fritz G; Kaina B
    Curr Cancer Drug Targets; 2006 Feb; 6(1):1-14. PubMed ID: 16475973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Statins in the treatment of tumors. Fiction or a new therapeutic approach?].
    Vítek L; Kráslová I; Muchová L; Krechler T
    Cas Lek Cesk; 2003; 142(6):323-8; discussion 329-30. PubMed ID: 12924030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer growth prevention by statins.
    Campbell MJ; Esserman LJ; Zhou Y; Shoemaker M; Lobo M; Borman E; Baehner F; Kumar AS; Adduci K; Marx C; Petricoin EF; Liotta LA; Winters M; Benz S; Benz CC
    Cancer Res; 2006 Sep; 66(17):8707-14. PubMed ID: 16951186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitors of HMG CoA reductase: new modes of action, new indications?].
    Essig M; Vrtovsnik F; Friedlander G
    Therapie; 2000; 55(1):43-9. PubMed ID: 10860000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins may ameliorate pulmonary hypertension via RhoA/Rho-kinase signaling pathway.
    Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
    Med Hypotheses; 2007; 68(5):1108-13. PubMed ID: 17097823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of statin therapy on colorectal cancer.
    Bardou M; Barkun A; Martel M
    Gut; 2010 Nov; 59(11):1572-85. PubMed ID: 20660702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.